General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
Pfizer collaborate to increase access to medicines and health care in China
Pfizer and microfinance specialist PlaNet Finance are collaborating on an in-depth research project on the healthcare needs of the working poor in China.
The Drum Beat - Issue 486 - Medicines Transparency: Access, Quality, and Accountability
This issue of The Drum Beat e-magazine, produced by the Communications Initiative Network, focuses on Medicines Transparency and highlights MeTA
Drug shortage hits Uganda
The latest survey from the Uganda Country Working Group shows 32-50 per cent of essential medicines for common diseases are not available
Measuring medicine prices, availability, affordability and price components 2ND EDITION
The second edition of the manual for the Health Action International/World Health Organization pricing survey tool.
Medicine Pricing Matters Issue 4
This issue includes interesting articles on pricing policy reforms in China and the establishment of retail outlets in India that sell only unbranded generics.
Untangling the Web of Antiretroviral Price Reductions
The 11th edition of this report shows the evolution of ARV prices and highlights the continuing gaps in treatments needed for patients in developing countries. Also available in Spanish, French and Portuguese.
Poverty, not pharmaceutical patents, is the leading factor to a lack of access to essential medicines in developing countries.
A study from the Royal Institute of International affairs suggests that rather than patents limiting access to essential medicines in developing countries, it is poverty.